Empera Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
- Revenue Growth 61.07%
- Profit Growth 4.71%
- Ebitda 55.68%
- Net Worth 70.15%
- Total Assets 98.99%
About Empera Meditech
Empera Meditech Private Limited (EMPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 2018 (Seven years 3 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.50 M.
Gayathiri Ponnusamy and Subburaj Mamitha serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85310TZ2018PTC029980
-
Company No.
029980
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Empera Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gayathiri Ponnusamy
|
Director | 06-Feb-2018 | Current |
|
Subburaj Mamitha
|
Director | 05-Dec-2023 | Current |
Financial Performance of Empera Meditech.
Empera Meditech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 61.07% increase. The company also saw a slight improvement in profitability, with a 4.71% increase in profit. The company's net worth Soared by an impressive increase of 70.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Empera Meditech?
Unlock access to Empera Meditech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Empera Biopharma Private LimitedGayathiri Ponnusamy is a mutual person
-
Quantas Bioscience Private Limited
Gayathiri Ponnusamy and Subburaj Mamitha are mutual person
-
Empera Health Service Private Limited
Gayathiri Ponnusamy is a mutual person
-
Empera Holdings Private Limited
Gayathiri Ponnusamy is a mutual person
Charges (Loans)
₹3.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.20 Cr
- Hdfc Bank Limited : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2023 | Others | ₹2.00 M | Open |
| 21 Sep 2021 | Hdfc Bank Limited | ₹1.50 M | Open |
How Many Employees Work at Empera Meditech?
Unlock and access historical data on people associated with Empera Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Empera Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Empera Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
